Cargando…
Single-Dose Intranasal Immunisation with Novel Chimeric H1N1 Expressing the Receptor-Binding Domain of SARS-CoV-2 Induces Robust Mucosal Immunity, Tissue-Resident Memory T Cells, and Heterologous Protection in Mice
Current COVID-19 vaccines can effectively reduce disease severity and hospitalisation; however, they are not considerably effective in preventing infection and transmission. In this context, mucosal vaccines are pertinent to prevent SARS-CoV-2 infection and spread. In this study, we generated a repl...
Autores principales: | Wang, Donghong, Deng, Yao, Zhou, Jianfang, Wang, Wen, Huang, Baoying, Wang, Wenling, Wei, Lan, Ren, Jiao, Han, Ruiwen, Bing, Jialuo, Zhai, Chengcheng, Guo, Xiaoyan, Tan, Wenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537001/ https://www.ncbi.nlm.nih.gov/pubmed/37766130 http://dx.doi.org/10.3390/vaccines11091453 |
Ejemplares similares
-
Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli
por: Wang, Wenling, et al.
Publicado: (2012) -
Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus
por: Lan, Jiaming, et al.
Publicado: (2018) -
Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022) -
Intranasal Immunisation with Recombinant Toxoplasma gondii Actin Partly Protects Mice against Toxoplasmosis
por: Yin, Li-Tian, et al.
Publicado: (2013) -
Mucosal immunisation and immunoprophylaxis as potential strategies for prevention of SARS
por: Foxwell, AR, et al.
Publicado: (2004)